Recent Headlines
ARUP Laboratories Presents Recent Research at Two Major Association Meetings
ARUP Laboratories staff has presented some recent research findings at two major meetings during the first two weeks of August. Posters were presented at the AMLI and ACM conferences. - August 12, 2010 - ARUP Laboratories
Colorado BioScience Association Seeks Region’s Top Innovators for Venture Showcase Competition at 2010 BioWest Conference & Expo
The organizers of the annual BioWest Conference & Expo are again looking for the best bioscience start-ups in the region as candidates for this year's $7,500 Dorsey & Whitney Venture Showcase Award. Four companies will be chosen to present at the showcase on Wednesday, September 29, 2010, and will be judged by a panel of venture capitalists. Deadline for entry is Friday, August 20. - August 04, 2010 - Colorado BioScience Association
Novus Biologicals Releases Two New Posters to Guide Antibody Research
Novus revealed two new posters at the ISSCR 8th Annual Meeting between June 16 - 19 – a fluorescent labels poster and a stem cell signalling pathway poster. The fluorescent labels poster displays all fluorophores that Novus offers conjugated to their primary antibodies. The stem cell... - August 04, 2010 - Novus Biologicals Europe
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Diabetic Neuropathy
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for diabetic peripheral neuropathy in its Worcester, MA facility. Diabetic neuropathy is a common complication of diabetes in which nerves are damaged as a result of high blood sugar levels. Symptoms... - July 31, 2010 - Clinical Pharmacology Study Group
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Psoriatic Arthritis
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for psoriatic arthritis in its Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for the... - July 31, 2010 - Clinical Pharmacology Study Group
American Society for Biochemistry and Molecular Biology Honors 11 Outstanding Scientists
The American Society for Biochemistry and Molecular Biology last week named 10 scientists the winners of the nonprofit’s annual awards. Another winner was announced earlier this year. The recipients, who will give talks at the society’s annual meeting April 9-13 in Washington, D.C., are... - July 30, 2010 - American Society for Biochemistry and Molecular Biology
International Stem Cell Corporation Planning European Subsidiary
International Stem Cell Corporation (OTCBB:ISCO) announced that it had entered into a Memorandum of Understanding with ARG Vermogensverwaltung AG ('ARG'), a German Investment Fund, to create a new European subsidiary ('ISCO Europe') to be funded with up to $10 million of capital derived from ARG... - July 28, 2010 - International Stem Cell Corporation
Glissandra™ Skincare Announces the Boutique Retail Launch of Its Innovative Anti-Aging Skincare Products at Toronto’s PIR Cosmetics
Glissandra™ Skincare is pleased to announce the boutique retail launch of its innovative anti-aging skincare products at PIR Cosmetics, widely recognized in the beauty industry as Canada's leading retailer of hard-to-find, niche cosmetics brands. Glissandra products target the leading cause of aging: mitochondrial decay. - July 28, 2010 - Glissandra Skincare
Pardee Grant Will Further Pancreatic Cancer Research
Seventy-five percent of pancreatic cancer patients die within the first 12 months of their diagnosis. In a collaborative project, George Prendergast, Ph.D., Professor, President & CEO at the Lankenau Institute for Medical Research (LIMR) and Iraimoudi Ayene, Ph.D., Associate Professor at LIMR, received a one-year $125,000 grant from the Elsa U. Pardee Foundation to conduct the research project entitled Novel Immunochemotherapy for Pancreatic Cancer Treatment. - July 28, 2010 - Lankenau Institute for Medical Research
ALPCO Diagnostics Launches First Commercially Available Sclerostin ELISA in the U.S.
ALPCO Diagnostics recently launched an ELISA specific for measuring human sclerostin in serum and plasma. Sclerostin inhibits osteoblast activity via antagonism of the wnt signaling pathway and plays a key role in the regulation of bone formation. Reports show that sclerostin expression and/or... - July 27, 2010 - ALPCO
Health Decisions Appoints New CTO to Streamline Its HD360° Trial Management Platform
CRO hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information. - July 24, 2010 - Health Decisions
ALN Publishes Article on Whole Animal Database by Noesys Data
Article on Artios Software Suite is published by ALN, a respected industry publication covering animal research institutions and markets. - July 21, 2010 - Noesys Data
$1.85 Million Grant Explores New Treatment for Rheumatoid Arthritis
Affecting more than 1.3 million people in the United States alone, rheumatoid arthritis (RA) is a debilitating disease that causes pain, swelling, and stiffness in the joints. Dr. Laura Mandik-Nayak, Assistant Professor at the Lankenau Institute for Medical Research (LIMR), received a five-year,... - July 21, 2010 - Lankenau Institute for Medical Research
Glycemion Strategies Announces the Availability of a New HbA1c & HS-CRP Combination Test for Dental Professionals
Glycemion Strategies announces the availability of a combination test specifically developed by Healthy Life Labs for diabetes and inflammation to serve the 150,000 dental professionals in the US and the millions of at-risk patients they serve. - July 18, 2010 - Healthy Life Laboratories
Healthy Life Laboratories Appoints Henry Warner as Computer Sciences Director
Healthy Life Laboratories, Inc., a clinical research laboratory in north suburban Chicago has appointed Henry A. Warner, MS as its Director of Computer Sciences. - July 17, 2010 - Healthy Life Laboratories
Re-Uniting Families on the Increase with DNA Diagnostics Centre UK
With the first UK ‘walk-in’ DNA Testing facility now open, DNA Diagnostic Centre UK confirms large numbers of families are being re-united through DNA immigration testing services. - July 14, 2010 - DNA Diagnostics Centre
International Stem Cell Corp. and India's Largest Eye Hospital to Develop Stem Cell-Based Treatment for Corneal Vision Impairment
International Stem Cell Corporation and Sankara Nethralaya Eye Hospital, a nonprofit medical facility, are collaborating to develop ISCO's 'CytoCor™' stem cell-derived corneal tissue. The goal is to use CytoCor, human tissue derived from pluripotent human stem cells, to treat corneal blindness and vision impairment. - July 11, 2010 - International Stem Cell Corporation
Unimed-Midwest Introduces Wrap-It™ Bandages – Versatile Wraps for Uniform Compression and Support
Wrap-It™ Bandages with hook and loop closures are ideal compression wraps and supports for medical needs and sports injuries. Available in a variety of sizes, these breathable, reusable bandages are machine washable, sterilizable and latex-free. - July 09, 2010 - Unimed-Midwest, Inc.
Stemedica Announces the Appointment of Dr. Cesar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica’s allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the United States. - July 02, 2010 - Stemedica Cell Techechnologies
Consumers Report Positive Results in Reducing Symptoms of Lactose Intolerance with Lactagen
Customer Experience Reports indicate relief from the symptoms of lactose intolerance using the Lactagen® program of colonic adaptation. - July 02, 2010 - Lactagen
Colorado BioScience Association Commends Boettcher Foundation on Historic Launch of Webb-Waring Biomedical Research Program & Inaugural Class of 'Boettcher Investigators'
Colorado BioScience Association commends Boettcher Foundation on launching the new Webb-Waring Biomedical Research Program and its 2010 (Inaugural) Class of Boettcher Investigators. This new grant program will ensure that the Webb-Waring legacy lives on both through the discovery of new knowledge that improves human health and through the investment in and advancement of early-career scientists. - July 01, 2010 - Colorado BioScience Association
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Rheumatoid Arthritis Studies
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for rheumatoid arthritis in their Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for... - June 25, 2010 - Clinical Pharmacology Study Group
Economic Development Executive Holli Baumunk Named President & CEO of the Colorado BioScience Association Effective July 12
Holli Baumunk, Vice President of the Metro Denver Economic Development Corporation for the past seven years, has been named President & CEO of the Colorado BioScience Association (CBSA) July 12. The announcement is made by Rick Jory, CBSA Board Chairperson, who says Baumunk was unanimously... - June 24, 2010 - Colorado BioScience Association
Houston IVF Announces Fertility Breakthrough with First Live Births in Texas from Frozen Egg
Houston IVF recently announced the first live births of children conceived using oocyte cryopreservation, also known as egg freezing, in the state of Texas. The births pave the way to successful pregnancies for women who face cancer treatment or women who want to delay childbearing due to their career or lifestyle situations. - June 24, 2010 - Houston IVF
"Love Simple," S.L.E. Lupus Foundation Donation Drive Drawing to a Close
June 21 Last Day for 30% of Sales on iTunes to Help Raise Funds, Awareness for Lupus - June 19, 2010 - S.L.E. Lupus Foundation
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Fibromyalgia Studies
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for fibromyalgia in their Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for the... - June 18, 2010 - Clinical Pharmacology Study Group
ALPCO Diagnostics Exclusively Offers Animal NGAL Assays from BioPorto
BioPorto Diagnostics has awarded ALPCO Diagnostics exclusive distributorship for its animal NGAL ELISAs to the North American market. BioPorto’s prominence is unrivaled in immunoassays for measuring NGAL (neutrophil gelatinase associated lipocalin) – the breakthrough kidney injury... - June 17, 2010 - ALPCO
Discover Past Secrets for Father’s Day with DNA Diagnostics Centre UK
DNA Diagnostics Centre UK (DDC) the leading DNA testing laboratory announces complimentary DNA sample collection in time for father’s day. - June 16, 2010 - DNA Diagnostics Centre
Romantic Comedy Film "Love Simple" Donating Proceeds to S.L.E. Lupus Foundation
June 14—June 21, 30% of Sales on iTunes Will Help Raise Funds, Awareness for Lupus - June 12, 2010 - S.L.E. Lupus Foundation
AsymmetRx Medical Signs Multi Year Agreement with Ventana Medical a Member of the Roche Group
AsymmetRx Medical, Inc. an Acton, MA based Biotechnology Company, announced the signing of a license agreement with Ventana Medical, A member of the Roche Group. This agreement provides Ventana with the exclusive license and distribution rights of their patented Prostate Cancer Diagnostic tool... - June 11, 2010 - AsymmetRx Medical, Inc.
Health Decisions CEO Explores Adaptive Monitoring Techniques for Late-Stage Clinical Studies in June 14 DIA Session
Dr. Michael Rosenberg will describe how fast access to metrics, flexible processes, and automated technology enable study monitors to increase efficiency - June 10, 2010 - Health Decisions
International Stem Cell Corporation's Parthenogenetic Stem Cell Patent Approved by the United States Patent and Trademark Office
International Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO a patent relating to the company’s development of human non-embryonic parthenogenetic stem cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, that could create a universal cell benefiting most the of the world's population, and that avoids ethical issues. - June 10, 2010 - International Stem Cell Corporation
ALPCO Diagnostics Prepares for Launch of Unique Immunoassays
ALPCO Diagnostics announces the recent hiring of Leon F. Hebert Jr., Ph.D. As ALPCO’s new Diabetes and Obesity Product Manager, Dr. Hebert will be charged with overseeing the launch of several new ELISA research tools, including: Mouse Proinsulin ELISA, Rat Proinsulin ELISA, Mouse C-peptide... - June 09, 2010 - ALPCO
The Allogeneic Adult Stem Cells Company Announcing Appointment of Dr. Lev Verkh
Lev Verkh is now a part of Stemedica, the allogeneic adult stem cells manufacturing company for effective stem cell clinical trials, thus improving the life of humans. - June 05, 2010 - Stemedica Cell Techechnologies
Application of Flow Cell to Continuous Processing Technology Webinar
METTLER TOLEDO announced that the webinar – The Application of the ReactIR Flow Cell to Continuous Process Technology - is now available on-demand. Presented by Professor Steven Ley of the University of Cambridge, METTLER TOLEDO is proud to offer this free online seminar that discusses the application of the ReactIR Flow Cell inline using various meso and micro scale flow chemistry equipment. - June 05, 2010 - METTLER TOLEDO
Buchberger Laboratories Austria Unveiling WOYZEK® Nicotine Inhaler
For the first time Buchberger Laboratories Austria is releasing detailed information on its most promising pharmaceutical product candidate – the WOYZEK® Nicotine Inhaler – a cigarette smoking cessation aid for medium and long-term use. - June 04, 2010 - Buchberger Laboratories Austria
Unimed-Midwest Introduces Insta-Cold Compress, Environmentally Friendly Instant Cold Pack
The Insta-Cold Compress instant cold pack is an easy to use, high-performing ice pack which is environmentally friendly and is composed of non-hazardous materials, unlike traditional instant ice packs. - June 03, 2010 - Unimed-Midwest, Inc.
Reaction Progress Kinetic Analysis to Study Organic Reactions Webinar
METTLER TOLEDO announced that the webinar - Reaction Progress Kinetic Analysis: A Powerful Methodology for Streamlining the Study of Complex Organic Reactions – presented by Donna Blackmond, of The Scripps Research Institute, is now available on-demand. METTLER TOLEDO is proud to offer this free online seminar that discusses how Reaction Progress Kinetic Analysis (RPKA) simplifies kinetic studies of organic reactions. - June 02, 2010 - METTLER TOLEDO
AAPS Highlights Use of Process Analytical Technology (PAT)
METTLER TOLEDO will attend the 2010 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting to discuss collaborative research carried out with pharmaceutical scientists. In advance of the conference, a list of previous American Association of Pharmaceutical Scientists (AAPS) presentations highlighting how pharmaceutical scientists use Process Analytical Technology (PAT) to further their research and optimize manufacturing processes using the principals of Quality by Design (QbD) - June 02, 2010 - METTLER TOLEDO
20 Years of Reaction Calorimetry at Johnson and Johnson
METTLER TOLEDO announced the webinar – 20 Years of Reaction Calorimetry at Johnson and Johnson: Developing Improved and Safer Processes – presented by Stephen M. Stefanick, of Johnson and Johnson, is now available on-demand. - June 02, 2010 - METTLER TOLEDO
How to Compare Lab Scale Mixing with Full Scale Process Vessel Performance Webinar
METTLER TOLEDO announced the webinar – The Importance of Mixing: How to Compare Lab Scale Mixing with Full Scale Process Vessel Performance – is now available on-demand. METTLER TOLEDO is proud to offer this free online seminar where presenter Ray Machado compares lab mixing and large scale mixing, while featuring two short courses he has given: Fundamentals of Scale-up and iControl Mixing Guidelines. - June 02, 2010 - METTLER TOLEDO
Swedish Alopecia Conference Attended by Nanogen Thinning Hair Researchers
Hair loss researchers Nanogen add Swedish Alopecia Conference to a long line of prestigious exhibitions they have attended. - May 30, 2010 - Nanogen
Health Decisions Encourages DIA Attendees to Demand More Than the Industry’s 10% Rate of On-Time Enrollment in Clinical Trials (Booth 929)
CRO demonstrates techniques that reverse the tide of enrollment delays in clinical research. - May 29, 2010 - Health Decisions
Governor Bill Ritter Jr. Signs Executive Orders Initiated by Colorado BioScience Association (CBSA) to Ensure Continued Investment in Life Sciences
Governor Bill Ritter Jr. signed two executive orders initiated by the Colorado BioScience Association (CBSA) today, calling for an online “Investment Opportunity Index” to classify opportunities for capital investment within the bioscience and cleantech industries, as well as a quarterly Roundtable on Venture Capital with the Governor – focusing on bioscience, renewable energy and aerospace. - May 28, 2010 - Colorado BioScience Association
Drs. Nasar and Cozzarelli Now on Staff at Jersey Shore
Drs. Alan Nasar and James F. Cozzarelli, orthopedic surgeons at Advanced Orthopedics and Sports Medicine Institutes (AOSMI), Freehold and Monroe townships, have been granted medical privileges at Jersey Shore Medical Center, Route 33, Wall, allowing them to offer a comprehensive range of orthopedic services, including surgery, to patients there. - May 24, 2010 - Advanced Orthopedics and Sports Medicine Institute, PC
Ritter Pharmaceuticals Launches Redesigned Website for Lactagen
Ritter Pharmaceuticals, Inc. announces the launch of a newly redesigned website for their lactose intolerance product, Lactagen (www.lactagen.com). - May 23, 2010 - Lactagen
International Stem Cell Corporation Enters Into Strategic Alliance to Automate Cornea Tissue Production
International Stem Cell Corporation (OTCBB:ISCO), www.intlstemcell.com, announced today that it had entered into a strategic alliance with The Automation Partnership (TAP), www.automationpartnership.com, to automate and scale up the production of stem cell-derived human corneal tissue. The alliance... - May 22, 2010 - International Stem Cell Corporation
Accord Clinical Research Announces Ulcerative Proctitis Research Studies in Daytona Beach, Florida
Accord Clinical Research, a privately owned research facility, located in Port Orange, Florida, announces their latest research study to test investigational treatment options for those already diagnosed with ulcerative proctitis. - May 21, 2010 - Avail Clinical Research
IonSense Issued Three Patents Related to Direct Analysis in Real Time Mass Spectrometry
Supports Current Products and Applications in Food Safety, Pharmaceutical Development, and Forensics - May 20, 2010 - IonSense, Inc.
Jean Brown Research Announces Participation in a Phase II/III Clinical Trial of Investigational Vaccine Used to Prevent Infection in Cardiothoracic Surgery Patients
Jean Brown Research Announces Its Participation in a Phase II/III Clinical Trial of an Investigational Vaccine Used to Prevent Staphylococcus Aureus Infection in Patients Undergoing Cardiothoracic Surgery. - May 19, 2010 - Jean Brown Research